 |
PDBsum entry 4zdl
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structural basis for early-Onset neurological disorders caused by mutations in human selenocysteine synthase.
|
 |
|
Authors
|
 |
A.K.Puppala,
R.L.French,
D.Matthies,
U.Baxa,
S.Subramaniam,
M.Simonović.
|
 |
|
Ref.
|
 |
Sci Rep, 2016,
6,
32563.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Selenocysteine synthase (SepSecS) catalyzes the terminal reaction of
selenocysteine, and is vital for human selenoproteome integrity. Autosomal
recessive inheritance of mutations in SepSecS-Ala239Thr, Thr325Ser, Tyr334Cys
and Tyr429*-induced severe, early-onset, neurological disorders in distinct
human populations. Although harboring different mutant alleles, patients
presented remarkably similar phenotypes typified by cerebellar and cerebral
atrophy, seizures, irritability, ataxia, and extreme spasticity. However, it has
remained unclear how these genetic alterations affected the structure of SepSecS
and subsequently elicited the development of a neurological pathology. Herein,
our biophysical and structural characterization demonstrates that, with the
exception of Tyr429*, pathogenic mutations decrease protein stability and
trigger protein misfolding. We propose that the reduced stability and increased
propensity towards misfolding are the main causes for the loss of SepSecS
activity in afflicted patients, and that these factors contribute to disease
progression. We also suggest that misfolding of enzymes regulating protein
synthesis should be considered in the diagnosis and study of childhood
neurological disorders.
|
 |
|
|
|
|
 |